Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05095532 · ClinicalTrials.gov registry record · Phase 1
Autologous Mesenchymal Stromal Cells and Islet Co-transplantation in TP-IAT
A Phase 1 study of Chronic Pancreatitis and Mesenchymal Stem Cells, sponsored by Medical University of South Carolina.
- Recruiting
- Registry status
- Phase 1
- Development phase
- 42
- Enrollment target
- 1
- Study location
NCT05095532 is a Phase 1 study of Chronic Pancreatitis and Mesenchymal Stem Cells that is actively recruiting participants, run by Medical University of South Carolina. The registered enrollment target is 42 participants, below the 688-participant average among 42 other Chronic Pancreatitis trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05095532, a Phase 1 study of Chronic Pancreatitis and Mesenchymal Stem Cells, is actively recruiting participants, sponsored by Medical University of South Carolina.
- RECRUITING
- Registry status
- Phase 1
- Development phase
- 42 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a clinical trial for chronic pancreatitis (CP) patients undergoing total pancreatectomy with islet autotransplantation (TP-IAT). Participants will be randomized to either bone marrow-derived mesenchymal stem cells (MSCs) or control with the standard of care. Participants will be followed for one-year post-transplant.
Conditions Studied
Interventions
- OTHER Placebo
- BIOLOGICAL Bone marrow-derived mesenchymal stem cells
Study Locations (1)
South Carolina
- Medical University of South Carolina - Charleston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 42 participants |
| Start Date | 2021-12-01 |
| Est. Completion | 2027-06-30 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05095532
The ClinicalTrials.gov registry entry for NCT05095532 describes a study currently listed as recruiting, categorized as Phase 1. The registered enrollment target is 42 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 688-participant average among 42 other Chronic Pancreatitis trials with a reported enrollment target (94% lower). The listed sponsor is Medical University of South Carolina, which has 755 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Chronic Pancreatitis appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT05095532 reports 1 study location spanning 1 distinct geographic area - top geographies include South Carolina.
Frequently Asked Questions
What is clinical trial NCT05095532 about?
NCT05095532 is a clinical study titled "Autologous Mesenchymal Stromal Cells and Islet Co-transplantation in TP-IAT". This is a clinical trial for chronic pancreatitis (CP) patients undergoing total pancreatectomy with islet autotransplantation (TP-IAT). Participants will be randomized to either bone marrow-derived mesenchymal stem cells (MSCs) or control with the standard of care. Participants will be followed for...
What is the current status of trial NCT05095532?
This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 42 participants. The study started on 2021-12-01. Estimated completion is 2027-06-30.
What conditions does trial NCT05095532 study?
This clinical trial studies the following conditions: Chronic Pancreatitis, Mesenchymal Stem Cells.
What interventions are being tested in trial NCT05095532?
The interventions under investigation include: Placebo (OTHER), Bone marrow-derived mesenchymal stem cells (BIOLOGICAL).
Who is sponsoring clinical trial NCT05095532?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05095532 being conducted?
This trial has 1 study location across South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Pancreatitis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Novel Cellular Therapy for the Treatment of Pain Associated With Chronic Pancreatitis
RECRUITING · Phase 1
-
Soy Tomato Juice to Improve Outcomes in Pancreatitis
RECRUITING · Phase 1
-
STTEPP: Safety, Tolerability and Dose Limiting Toxicity of Lacosamide in Patients With Painful Chronic Pancreatitis
RECRUITING · Phase 1
-
Carbon Monoxide-Saturated Medium for Islet Isolation
COMPLETED · Phase 1
-
Trial of Indomethacin in Chronic Pancreatitis
COMPLETED · Phase 1
-
Evaluation of a Mixed Meal Test for Diagnosis and Characterization and Type 3c Diabetes Mellitus Secondary to Pancreatic Cancer and Chronic Pancreatitis (DETECT)
RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.